PREDICT is an online prognostication and treatment benefit tool (http://www.predict.nhs.uk) that is based on clinico-pathological factors including tumour size, tumour grade, lymph node status, ER status, HER2 status and mode of detection. This evidence concerns the gene ERBB2 and neoplasm.